$TMDX (TRANSMEDICS GROUP) — 8-K: TransMedics names Fernando Araujo CFO and reiterates 2026 revenue guidance of $737M–$757M

TransMedics appointed Fernando Araujo as Chief Financial Officer effective September 21, 2026, succeeding Gerardo Hernandez, who transitions to Commercial Strategic Advisor, LATAM. The company reiterated full-year 2026 revenue guidance of $737 million to $757 million, representing approximately 22% to 25% year-over-year growth. Guidance excludes any revenue contribution from the strategic investment in PAD Aviation Service GmbH. TransMedics expects to revisit the outlook with third quarter 2026 results.

TransMedics appointed Fernando Araujo as Chief Financial Officer effective September 21, 2026, succeeding Gerardo Hernandez, who transitions to Commercial Strategic Advisor, LATAM. The company reitera